A5084906582- Pharmaceutical Economics and Policy
- Public Health in Brazil
- Biotechnology and Related Fields
- COVID-19 and Mental Health
- Health Systems, Economic Evaluations, Quality of Life
- International Development and Aid
- Pharmaceutical industry and healthcare
- Business, Innovation, and Economy
- Olfactory and Sensory Function Studies
- Medical Malpractice and Liability Issues
- Intellectual Property and Patents
- Taxation and Compliance Studies
- Ethics and bioethics in healthcare
- Innovation and Socioeconomic Development
- Healthcare Systems and Reforms
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Stress and Burnout Research
- Viral Infections and Outbreaks Research
- Pharmaceutical Practices and Patient Outcomes
- Religion, Society, and Development
- Public Health and Social Inequalities
- Politics and Society in Latin America
- Community Health and Development
- Political Influence and Corporate Strategies
- Child and Adolescent Psychosocial and Emotional Development
Universidad de Los Andes
2013-2024
Universidad de Los Andes
2020-2022
Universidad Nacional de Colombia
2021
Pan American Health Organization (Cuba)
2021
John Brown University
2015-2021
Universidad del Rosario
2020
Brown University
2015
To describe the current status of regulatory reliance in Latin America and Caribbean (LAC) by assessing countries' frameworks to approve new medicines, ascertain, for each country, which foreign regulators are considered as trusted authorities rely on.Websites from LAC were searched identify official regulations drugs. Data collection was carried out December 2019 completed June 2020 countries. Two independent teams collected information regarding direct recognition or abbreviated processes...
High pharmaceutical expenditure is one of the main concerns for policymakers worldwide. In Colombia, a middle-income country, outpatient prescription represents over 10% total health in mandatory benefits package (POS), and close to 90% complementary government fund (No POS). order control expenditure, since 2011, Ministry Health introduced price caps on inpatient drugs reimbursements by active ingredient. By 2013, more than 400 different products, covering 80% public were controlled. This...
Abstract In this article, we examine three different cases in which health activists lobbied the World Health Organization and its member states to regulate marketing practices of multinational companies. The campaign against tobacco manufacturers resulted a binding treaty; infant formula non‐binding code conduct; pharmaceutical failed. We show that existing arguments regarding success global social movements transnational advocacy networks fail explain divergent outcomes these cases....
COVID-19 has exposed, reproduced, and created new inequalities in Latin America the world. In this introductory paper, we discuss impact of extant inequities on vulnerability to but also identify new, some unexpected, vulnerabilities. We emphasize vulnerabilities disease as well policies other responses fight against COVID-19. Building insights from Peter Hall Michele Lamont's work social resilience, draw papers special issue important role state addressing types resilience that vulnerable...
There is growing interest in pharmaceutical innovation low- and middle-income countries (LMICs), but information on existing activities, capacities, outcomes scarce. We mapped available data at the global level, studied national systems of Bangladesh Colombia to shed light research development (R&D) Global South, including challenges prospects, help fill knowledge gaps. gathered analyzed from three types sources: literature, semi-structured interviews with key informants, publicly R&D...
Forcibly displaced adolescents face increased risks for mental illness and distress, with adolescent girls disproportionately affected in part due to heightened gender inequity. Although the family unit has potential promote healthy development adolescents, few interventions have employed a transformative approach or included male siblings maximize benefits girls.
International agreements on Intellectual Property (IP) have proven to be a good example study global lawmaking. Beginning by looking at the 1990s Trade-Related Rights (TRIPS) agreement and into negotiation implementation of regional national trade agreements, this article reflects intricate relationship between international IP public health. The comprehensive analysis these rules their effect provides valuable insights dynamic interplay domestic factors in shaping health policies. Building...
El 2 de junio 2021, el Ministerio Salud y Protección Social Colombia expidió la Resolución 777, mediante cual se determinan las condiciones para reinicio todas actividades económicas sociales restringidas. Asimismo, en esta resolución define Índice resiliencia epidemiológica municipal (IREM) como herramienta apoyar toma decisiones relacionadas con reactivación económica medio del tercer pico epidémico COVID-19 país. objetivo este artículo es hacer un análisis crítico los aspectos técnicos...
We greatly appreciate the comments made by Rojas-Botero et al.1 on our paper entitled “Critical reflections Municipal Epidemiological Resilience Index used for public policy decision-making regarding control of COVID-19 pandemic in Colombia”.2 acknowledge that health, understood as well-being community, should be focus all efforts health professionals. In this sense, amid a major emergency, such one we are currently experiencing due to pandemic, requires balanced and calm judgment considers...
La tutela, el mecanismo de garantía los derechos constitucionales en Colombia, es uno más usados Latinoamérica. Los colombianos pueden presentar tutelas por cualquier violación a sus constitucionales, ante juez y formato sin necesidad ser representados un abogado (Presidencia la República Colombia. Decreto 2591 1991). Es esto parte lo que ha facilitado durante últimos 10 años litigio derecho fundamental salud, haya aumentado considerablemente país.
We conducted an audit study with 262 community pharmacies from seven municipalities in the Northeast of Colombia. In study, a simulated client called and described list symptoms experienced by her brother, asked pharmacist for recommendation. our "common" condition, were headache, sore throat, fever. COVID we added anosmia (i.e., loss smell) as fourth symptom, allowing better discrimination respect to other diseases. find that mentioning induced more cautious behavior among pharmacists. The...
Background: Price caps through international reference pricing are widely used around the World, but not so commonly in over-the-counter markets (OTC). We study this type of regulation for case oral contraceptives Colombia, which is a de facto OTC market. Objectives: aim to establish whether triggered competitive response within and across product categories (active pharmaceutical ingredients).We also regulated products targeted customers from high socio-economic status now distributed...